Generic Gabitril® Launches

Released: 11/21/2012   By: Mike Partridge, RPh

On October 18, Caraco received final FDA approval and launched the generic equivalent of Teva Pharmaceutical’s branded product Gabitril®. Gabitril® is indicated as adjunctive therapy in adults and children 12 years or older in the treatment of partial seizures.
Note: Gabitril® can also be prescribed to relieve nerve pain and muscle spasticity.